Ember Therapeutics Inc (CE) (EMBT) 銘柄情報

How to wipe out your account in one day. $EMBT

This is the shit I’m taking about. People are so dumb n lazy. This is why i don’t fault @RobinhoodApp. @CNBC mentions Ember cold storage for vaccine and people rush to buy $EMBT bc the name is Ember Therapeutics, a defunk pinksheet. Stock up 5000%. @jimcramer we gota teach them. pic.twitter.com/4h3xwr1Lbv— Michael Edward (@MikeEdward_TTG) December 16, 2020

wow

Jus browse twitter - the usual suspects

Short Squeezed on this one!! $EMBT

up 1,000% today and no posts. What is going on?

8k out friday ah about PR that never hit OTCM https://www.otcmarkets.com/filing/html?id=12934395&guid=t8oEU6UER5vtath

Ember Therapeutics Enters Into Agreement to Divest OP-1 Portfolio Program to Viscogliosi Brothers, LLC
Published 3:53 PM ET Thu, 16 Aug 2018 PR Newswire


NEW YORK, Aug. 16, 2018 /PRNewswire/ -- Ember Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the clinical application of Bone Morphogenetic Protein-7 (BMP-7), announced today that it has entered into a letter of intent with Viscogliosi Brothers, LLC (VB), a private equity investment firm focused on developing innovative neuromusculoskeletal technologies, for the sale of its OP-1 product family and related assets, which includes OP-1 Implant, OP-1 Putty, Opgenra and Osigraft for use in orthopaedic bone applications.

Ember Therapeutics had acquired the exclusive, worldwide license to the BMP-7 and OP-1 portfolio and associated intellectual property from Stryker Corporation in 2014. The previously commercialized OP-1 product portfolio had at one point generated approximately $100M in annual revenues for Stryker and had been viewed as a formidable competitor to Medtronic's Infuse.

The transaction is expected to close in late Q3 or Q4 of this year and is subject to financing. "This transaction allows Ember to continue to focus on our exciting late stage osteoarthritis (OA) program which offers the potential of addressing the actual cause of this debilitating disease by regrowing cartilage in the knee. OP-1, a related product for bone, has an immense amount of potential as has been previously used in over 50,000 patients," stated Joseph Hernandez, Executive Chairman of Ember Therapeutics. "We are excited to be working with the Viscogliosi Brothers in their efforts to commercially relaunch these products."

"We believe bone repair and regeneration is the future of orthopaedic healthcare," stated Anthony G. Viscogliosi, principal of Viscogliosi Brothers, LLC. "VB is delighted to have access once again to the previously commercialized OP-1 product family formerly owned by Stryker Biotech. This is the second publicly announced step VB has taken in the direction of assembling what we believe will be the leading global portfolio of BMP technology for stimulating bone growth."

About Ember Therapeutics, Inc.

Ember Therapeutics, Inc. is a pharmaceutical company developing targeted therapies for pain, osteoarthritis, kidney fibrosis and other regenerative medicines. In particular, Ember Therapeutics, Inc. has two commercial stage products and a late stage Phase 3 ready assets. For more information, please visit www.embertx.com.

About Viscogliosi Brothers, LLC

Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City, in 1999, Viscogliosi Brothers, LLC (VB), is a family office holding company specializing in venture capital, private equity and merchant banking in the neuro-musculoskeletal/orthopedic industry.

VB's vision is dedicated to improving healthcare and the quality of life for humanity by finding innovative orthopedic concepts and supporting them to become sustainable technologies that can be commercialized globally to lead the evolution in orthopedic standards of care.

To accomplish this vision, VB discovers technologies, creates products and develops, builds, operates and finances companies founded on innovative and "life changing" technologies. VB principals have participated in more than 300 transactions, have invested in more than 20 companies and have formed more than ten funds.

Companies and funds that VB participated in have generated more than $1.5 billion in exit proceeds for investors through 14 exits in the last 18 years. Through its portfolio companies VB has defined 7 new orthopedic industry categories and its investments have helped commercialize more than 75 medtech devices, including eleven number one orthopedic technologies in seven market leading businesses.

VB orthopedic portfolio companies' products have been implanted in nearly 300,000 people in more than 70 countries globally.

For more information, please visit www.vbllc.com.

i was doing a little browsing and noticed EMBT had an 8k on July 12th.

what's with this stock? i have a small position tucked inside my 'Tomorrow' drawer, and i'm wondering if i should lock it instead inside a time capsule. its come down to .25 x .35, and the minimalist 2500 shares offered was bought, but i notice that didn't take out the ask. obviously they're still doing business (of a sort,) but the stock itself has either gone into hibernation mode, or is inert.

i'm trying to patiently wait this one out, but i'm feeling rather poorly at the moment.

::sigh:

rich


*******************

On May 19, 2017, Ember Therapeutics, Inc. (“Ember Therapeutics”) entered into a Contribution Agreement (“DermaSilk Agreement”) with DermaSilk Brands, Inc. (“DermaSilk”), a Delaware corporation. Pursuant to the DermaSilk Agreement, DermaSilk acquired the sole ownership interest in DermaSilk Brands business, including all assets and liabilities related thereto, and DermaSilk became a wholly owned subsidiary of Ember Therapeutics. The DermaSilk Agreement isa ttached as Exhibit 99.1.

Also on May 19, 2017, Ember Therapeutics entered into a Contribution Agreement (“Migralex Agreement”) with Migralex, Inc. (“Migralex”) a Delaware corporation. Pursuant to the Migralex Agreement, Migralex acquired the sole ownership interest in the Migralex business, including all assets and liabilities related thereto, and Migralex became a wholly owned subsidiary of Ember Therapeutics. The MigralexAgreement is attached as Exhibit 99.1.

************

Guess the headache meds didnt get renewed by CVS? The last bottle I bought was expired by a few months and I havent noticed it the last few locations Ive gone to.

EMBT my biggest disappointment 2016. What in the world happened with these guys? lowest damn float Prior NASDAQ CEO and he lets it go dark????? Totally sucks here. Was hoping this would be 3 to 5 bucks.....

Disappointed this hasnt gotten higher. Heck they cant even get filings right for their 2 stocks. How were they going to operate a NASDAQ big board if they cant even get the filings right for MICB and EMBT? I totally read this dude wrong... CEO is going to get his MICB revoked if he doesnt get those filings out....

$EMBT news baby!!!

8k out.

Item 1.01 Entry Into A Material Definitive Agreement

On September 8, 2016, we entered into an Asset Purchase Agreement (the "Agreement") with Midwood Distributors, Inc., a New York corporation ( "Midwood Distributors"). Under the Agreement, we acquired all assets related to Dermasilk Brands, a line of anti-aging skin care products.

Under the Agreement, we have acquired all material assets currently owned by Dermasilk, including all inventory, raw materials, work in process, packaging, the toll free number, hardware and software used for ordering and customer support, all intellectual property, websites, domain names, accounts receivable and vendor credits, contracts, and all marketing and promotional information and materials.

The purchase price for the Dermasilk assets consisted of common stock and warrants, paid as follows:
• 2,105,263 shares of common stock at purchase price of $0.95.

This baby is going to sky rocket

Heck yes!! It's been a long wait

NEWS!!

NEW YORK , Sept. 12, 2016 (GLOBE NEWSWIRE) -- Ember Therapeutics, Inc. (OTCQB:EMBT), a diversified New York -based pharmaceutical company developing targeted therapies for osteoarthritis, kidney fibrosis, and other regenerative medicines, today announced that it has entered into a definitive agreement for the acquisition of Dermasilk™ Brands, a commercially available over-the-counter beauty product portfolio encompassing fourteen different products. The products are currently sold at several large retailers including Rite-Aid , CVS, Wal-Mart and K-Mart .
As part of the transaction, all assets from Dermasilk Brands, Inc. will be transferred to Ember Therapeutics, Inc.
“This is our third acquisition this year. The addition of the Dermasilk™ brand of products to our product line will allow us to expand on our current relationship with major retailers and provide additional revenues to Ember. Dermasilk products have a large customer following and are developed using the highest cutting edge science,” said Joseph Hernandez , Executive Chairman of Ember Therapeutics, Inc. “The revenues generated by these products and Migralex™, our other commercially available product, will help further the development of our two Phase 3 ready clinical programs in osteoarthritis and regenerative medicine.”

Dermasilk™ products are currently available at Rite-Aid , CVS, Wal-Mart , K-Mart , local pharmacies, and online at jet.com and the product website www.dermasilkbrands.com. To learn more about Dermasilk™ please access www.dermasilkbrands.com.
About Ember Therapeutics, Inc.

Ember Therapeutics, Inc. is a diversified pharmaceutical company commercializing and developing targeted therapies for pain, osteoarthritis, kidney fibrosis and other regenerative medicines. In particular, Ember Therapeutics, Inc. has a commercial stage pain product and two late stage Phase 3 ready assets. For more information, please visit www.embertx.com.

$EMBT $1 :)

SEC filings coming soon! http://www.embertx.com/sec.html

$1 up $EMBT

Good Morning!!! $EMBT

.73x.90 bids coming in

Good Morning $EMBT. Let's see if we can close near the high of the week

.90,$1.3, then $4

.90 up

Gonna add another 650 sometime this week. All these small adds I am starting to have a very nice size position here :)

$7,000 bid someone trying to load a nice chunk here

Huge bid in at .70 time for us to go back well over a $1. Us longs have been accumulating as many as we can. $EMBT working with Knight is huge $$$

bid raised to .7

10k bid at .65

I was saying it from beginning that this had 5.00+ written all over it. I think it still does for sure. I would even try to sneak in 1.50s of MICB too. someone had 2k for sale there the other day. But 1.00 would be better. Both these stocks are poised for major moves.

$EMBT slapping the ask time. Getting this well over a $1

.75x$1.00 and the ask is thin. Thinking we got any new short term flippers that came in Friday out. We don't want flippers. We want longs to get this to the proper price. At least $5+ imo $EMBT

When you have a $1Billion plus company(Knight Therapeutics Inc) you don't need hope lol. This isn't a stinky pinky. Billion dollar company's only work with legit companies. $EMBT my favorite sleeping gem

Not true I just try to be realistic and not pump every stock I touch.

We prob need to DD the other acquisitions as well just to see the potential value of those acquisitions and what they were for. Most of those biotech brains know what they are looking at. Im still a beginner with those things.


Like MICB made a deal with this other OTC. they were going to use that particular cos delivery system for their patents.


But heck EMBT has over 400 patents. Im not sure how many patents usual biotechs have but 400 sounds like A LOT!

Nope not hoping at all. Every chance I get I add. Spend 5 mins doing dd and you know you don't have to hope. Love this company. See this is why I asked why you are here. Such a negative person. All the time on every stock.

Gotcha. Hold and hope lol

Long term play. Been here awhile accumulating and holding for the gold

Need some buyers here...

Yep, a very strong chance imo

Yep $EMBT loving it

Its ok. We will prob be 1.50 then 2.00 soon enough. This is one of my fav otc right now. It will all be done regardless and be done legit too.

I think this actually has ATH* possibilities. That ran from this range to $10.

Contrary to what some idiots may think, I do own shares here (wouldn't touch that BK POS though). I was simply stating that I had hoped for a little more volume after the nice pop on Friday. People are far too sensitive.

Huh? What's your problem?

I got another 700 shares yet again today ;)

Why are you here

.65 x 1.02 Thought it might take off today. Guess not.

$1.25 let's go!!!!

Only 610 left at $1.25

I think the trading float is 10% of the actual float. Only a few shares were dropped initially. probably some ancient holder that had no idea what was going on. Now this is top of the line RM. You know they are going to put the Migralex thing out on some mailers or something in the future that will make this go to several dollars.



They are going to be making more and more deals as well. This will be huge soon